Search results for PX-TA1303
Showing 1 – 10 of1products

ID: BAB994548349
Simtuzumab Biosimilar – Anti-LOXL2 mAb – Research Grade, ProteoGenix, PX-TA1303
Description of Simtuzumab Biosimilar - Anti-LOXL2 mAb - Research Grade General information on Anti-LOXL2[Homo sapiens] (Simtuzumab) Monoclonal Antibody Simtuzumab has beeninvestigated for the treatment of Myelofibrosis, Pancreatic Cancer, Colorectal Cancer, and Idiopathic Pulmonary Fibrosis.
Host
Reactivity
Applications
Conjugation
Request a product
Please provide the required information below so that we can quickly source your products.
